HIV Pregnancy Hotline Homepage
Medical Information Linking Patients to Care Rapid HIV Testing
About The Hotline
> About the Hotline > Hotline FAQ > Hotline Release of Information Forms > Support Us
HIV Treatment Guidelines & Medical Information
> HIV Treatment Guidelines & Medical Information > Treatment Guidelines > Pregnancy and HIV FAQ > Neonatology/Pediatrics and HIV FAQ > Recent Articles
Rapid HIV Testing
> Rapid HIV Testing > Rapid HIV Testing FAQ > Forms for Reporting a Preliminary Positive Rapid HIV Test > Forms for Monthly Perinatal HIV Reporting  > Rapid HIV Testing Implementation Resources > Expedited Western Blot Test Information
Enhanced Case Management
> Enhanced Case Management > Enhanced Case Management FAQ > Enhanced Case Management Consent Forms > Case Management Protocols > Real Life Patient Stories
Resource Center & Forms
> Resource Center & Forms > All Forms > Updates > Helpful Links > Other HIV Hotlines
Information for Providers
> Information for Providers > Obstetric Health Care Providers > Pediatric Health Care Providers > Social Service Providers
Pregnant & Positive
> Pregnant & Positive > Pregnancy and HIV FAQ > Support Groups > HIV Prenatal Classes
Illinois Perinatal HIV Prevention Act
> Illinois Perinatal HIV Prevention Act > IL Perinatal HIV Prevention Act FAQ > Reporting Requirements
Our Partners
> Our Partners > Pediatric AIDS Chicago Prevention Initiative > Perinatal Rapid Testing Implementation Initiative in Illinois > Illinois Department of Public Health > AIDS Foundation of Chicago > Sources of HIV related Obstetric and Pediatric Care
Contact Us Get Involved  
 Follow Us

For non-pregnancy related questions about HIV, please call 1-800-AID-AIDS


Updated Adult & Adolescent Treatment Guidelines Available - 3/27/2012

The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents released updated Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents. Key changes include:

  • New section on HIV and the older patient
  • New table on cost of antiretroviral drugs
  • Updated recommendations on initiation of antiretroviral therapy (ART) in treatment-naive individuals
  • Expanded discussion of use of hormonal contraceptives in HIV-infected women
  • Preliminary recommendations on coadministration of the newly approved hepatitis C virus (HCV) NS3/4A protease inhibitors (PIs) boceprevir and telaprevir
  • Recommendations on “when to start” ART in HIV-infected individuals diagnosed with tuberculosis but not receiving ART
  • Discussion of the role of effective ART in preventing HIV transmission
To view the Guidelines, click here.